JRSIS Health Care Corporation
JRSS · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $138 | $4 | $223 | $597 |
| % Growth | 3,243.8% | -98.1% | -62.7% | – |
| Cost of Goods Sold | $113 | $4 | $196 | $411 |
| Gross Profit | $25 | $4 | $27 | $186 |
| % Margin | 18% | 100% | 12.1% | 31.2% |
| R&D Expenses | $2 | $1 | $29 | $10 |
| G&A Expenses | $4 | $2 | $97 | $186 |
| SG&A Expenses | $6 | $3 | $204 | $295 |
| Sales & Mktg Exp. | $3 | $1 | $107 | $109 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $8 | $4 | $233 | $305 |
| Operating Income | $17 | -$0 | -$206 | -$119 |
| % Margin | 12.1% | -4.5% | -92.5% | -19.9% |
| Other Income/Exp. Net | $0 | $0 | -$14 | $2 |
| Pre-Tax Income | $17 | -$0 | -$220 | -$117 |
| Tax Expense | $0 | $0 | $0 | $3 |
| Net Income | $17 | -$0 | -$188 | -$102 |
| % Margin | 12.2% | -2.7% | -84.4% | -17.1% |
| EPS | 0.002 | 0 | -0.002 | -0.001 |
| % Growth | – | 100% | -83.3% | – |
| EPS Diluted | 0.002 | 0 | -0.002 | -0.001 |
| Weighted Avg Shares Out | 8,460 | 84,599 | 84,599 | 84,599 |
| Weighted Avg Shares Out Dil | 8,460 | 84,599 | 84,599 | 84,599 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | -$21 | $14 | $16 |
| Depreciation & Amortization | $9 | -$3 | $13 | $13 |
| EBITDA | $25 | -$0 | -$193 | -$88 |
| % Margin | 18.4% | -2.6% | -86.6% | -14.7% |